Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jude Samulski

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
Nature Reviews. Genetics|February 12, 2020
Engineering adeno-associated virus vectors for gene therapyChengwen Li, R Jude Samulski
Human Gene Therapy|October 30, 2013
An emerging adeno-associated viral vector pipeline for cardiac gene therapyAravind Asokan, R Jude Samulski
Human Gene Therapy|April 20, 2022
Recombinant Adeno-Associated Virus Production, the Beginning of the End of UncertaintyWeidong Xiao, R Jude Samulski
Annual Review of Virology|March 10, 2016
AAV-Mediated Gene Therapy for Research and Therapeutic PurposesR Jude Samulski, Nicholas Muzyczka
Virology|April 13, 2005
Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector productionChengwen Li, R Jude Samulski
Nature Biotechnology|February 9, 2006
AAV does the shuffleAravind Asokan, R Jude Samulski
Hepatology (Baltimore, Md.)|May 23, 2013
Hepatic gene therapy using lentiviral vectors: has safety been established?David Dismuke, R Jude Samulski
Expert Opinion on Orphan Drugs|September 27, 2016
Recombinant adeno-associated virus vectors in the treatment of rare diseasesEric Hastie, R Jude Samulski
Human Gene Therapy|March 27, 2015
Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspectiveEric Hastie, R Jude Samulski
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 16, 2002
The adeno-associated virus crystal: impact inversely proportional to sizeJoseph E Rabinowitz, R Jude Samulski
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
Nature Reviews. Genetics|February 12, 2020
Engineering adeno-associated virus vectors for gene therapyChengwen Li, R Jude Samulski
Human Gene Therapy|October 30, 2013
An emerging adeno-associated viral vector pipeline for cardiac gene therapyAravind Asokan, R Jude Samulski
Human Gene Therapy|April 20, 2022
Recombinant Adeno-Associated Virus Production, the Beginning of the End of UncertaintyWeidong Xiao, R Jude Samulski
Annual Review of Virology|March 10, 2016
AAV-Mediated Gene Therapy for Research and Therapeutic PurposesR Jude Samulski, Nicholas Muzyczka
Virology|April 13, 2005
Serotype-specific replicating AAV helper constructs increase recombinant AAV type 2 vector productionChengwen Li, R Jude Samulski
Nature Biotechnology|February 9, 2006
AAV does the shuffleAravind Asokan, R Jude Samulski
Hepatology (Baltimore, Md.)|May 23, 2013
Hepatic gene therapy using lentiviral vectors: has safety been established?David Dismuke, R Jude Samulski
Expert Opinion on Orphan Drugs|September 27, 2016
Recombinant adeno-associated virus vectors in the treatment of rare diseasesEric Hastie, R Jude Samulski
Human Gene Therapy|March 27, 2015
Adeno-associated virus at 50: a golden anniversary of discovery, research, and gene therapy success--a personal perspectiveEric Hastie, R Jude Samulski
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 16, 2002
The adeno-associated virus crystal: impact inversely proportional to sizeJoseph E Rabinowitz, R Jude Samulski
Pageof 17